CIPLA REFLUX RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack (Suspension from the ARTG under s.29D(1)(b))
Product name
CIPLA REFLUX RELIEF ranitidine (as hydrochloride) 150mg tablet strip pack
Sponsor
Date action takes effect
Lapse date
Compliance action
Medicine suspension
Type of action
Suspension from the ARTG under s.29D(1)(b)
Grounds for regulatory action
Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable.
Suspension effective for 6 months. A decision was made to extend the suspension for a further 6 months in accordance with section 29E of the Act.